$CODX doesn't CODX screen for cancer? Look at this deal: 11:56 AM EDT, 09/16/2020 (MT Newswires) -- Biotech company Illumina(ILMN) is in discussion to buy Grail Inc., Bloomberg reported on Wednesday, citing people familiar with the matter. According to the unnamed sources, Grail, an early cancer-detection startup, could be valued more than $6 billion. The two health care companies could announce a deal as early as this week but no final decision has been made, the report said.
  • 5
  • 1
5 Likes